Congenital Nasolacrimal Duct Obstruction - Early Diagnosis and Graded Therapeutic Approach as Key Points for

Jens Heichel1

  • 1Department of Ophthalmology, Martin Luther University, Halle, Germany.

PubMed

Insights

Congenital nasolacrimal duct obstruction (CNLDO) in children can be effectively treated with a staged approach, achieving a 95% cure rate. This method prioritizes conservative and minimally invasive interventions for optimal outcomes.

Area of Science:

  • Ophthalmology
  • Pediatric Medicine

Background:

  • Epiphora in children often indicates Congenital nasolacrimal duct obstruction (CNLDO).
  • Differential diagnosis for epiphora should also include ocular surface inflammation, intraocular pathologies, and congenital glaucoma.

Purpose of the Study:

  • To review the literature on Congenital nasolacrimal duct obstruction (CNLDO).
  • To categorize and summarize therapeutic interventions for CNLDO.
  • To outline the existing staged therapeutic concept for managing CNLDO.

Main Methods:

  • A comprehensive literature review was performed.
  • Therapeutic steps for CNLDO were categorized.
  • A staged therapeutic concept was summarized.

Main Results:

  • A staged therapeutic concept for CNLDO yields approximately 95% cure rates.
  • The concept involves five steps of increasing complexity: conservative techniques, probing and syringing, transcanalicular approaches (with or without intubation), and dacryocystorhinostomy.
  • Conservative and minimally invasive interventions are prioritized.

Conclusions:

  • A stepwise, individualized management approach for CNLDO is recommended.
  • This strategy aims to preserve the anatomical structure of the nasolacrimal system.
  • The staged concept facilitates effective treatment for children with CNLDO.
Abstract